Tumor Necrosis Factor Receptor Superfamily, Member 6b, Decoy (TNFRSF6B) ELISA Kits

TNFRSF6B belongs to the tumor necrosis factor receptor superfamily. Zusätzlich bieten wir Ihnen TNFRSF6B Antikörper (89) und TNFRSF6B Proteine (11) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
TNFRSF6B 8771 O95407
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top TNFRSF6B ELISA Kits auf antikoerper-online.de

Showing 2 out of 6 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Lieferzeit Preis Details
Human 0.039 ng/mL 0.156-10 ng/mL Typical standard curve 96 Tests 15 bis 18 Tage
$910.56
Details
Human 0.03 ng/mL n/a   96 Tests 11 bis 16 Tage
$591.25
Details

Am meisten referenzierte TNFRSF6B ELISA Kits

  1. Human TNFRSF6B ELISA Kit für Sandwich ELISA - ABIN1979508 : Lancrajan, Schneider-Stock, Naschberger, Schellerer, Stürzl, Enz: Absolute quantification of DcR3 and GDF15 from human serum by LC-ESI MS. in Journal of cellular and molecular medicine 2015 (PubMed)
    Show all 2 Pubmed References

Weitere ELISA Kits für TNFRSF6B Interaktionspartner

Human Tumor Necrosis Factor Receptor Superfamily, Member 6b, Decoy (TNFRSF6B) Interaktionspartner

  1. significantly higher levels of TL1A and its decoy receptor DcR3 in RA patients than in controls; TL1A is significantly related to the disease activity and enhances IL-17 production

  2. Aberrant expression of DcR3, which is upregulated by oestrogen 25, is an important pathogenic factor in inducing endometriosis.

  3. High DCR3 expression is associated with coronary artery disease.

  4. Given the differential immune responses and evasion mechanisms in breast cancer, we expect to identify different breast cancer groups based on their expression of immune-related genes. TGF-beta and DcR3 are potential novel drug targets for breast cancer immunotherapy.

  5. The combination of decoy receptor 3, soluble urokinase type plasminogen activator receptor, and procalcitonin improved the sensitivity and specificity of diagnosis of sepsis, suggesting that use of the combination of three indexes enhanced the efficiency of sepsis diagnosis.

  6. Compared with the control, miR-340 was significantly lower in the serum of hepatocellular carcinoma patients (p<0.01). miR-340 was lower in HCC tissues than in adjacent; however, DcR3, TGF-beta1 and Smad2 were higher.

  7. DcR3 treatment caused HepG2 cell cytoskeleton remodeling, inhibited E-cadherin expression, and promoted cell migration.

  8. DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma risk in Northeast Chinese females

  9. Study found that both transcriptional expression and post-transcriptional DcR3 expression DcR3 expression were significantly up-regulated in colorectal cancer (CRC) tissues. DcR3 was found to be playing a critical role in CRC proliferation and migration in vitro and in tumorigenesis and metastasis in vivo.

  10. Higher plasma DcR3 level was related to better coronary collateral circulation (CCC) formation and displayed potent predictive power for CCC status in patients with coronary artery disease.

  11. High serum DcR3 levels are associated with disease severity in nonatopic asthma patients.

  12. Results show that DcR3 engages TNF ligands: FasL, LIGHT, and TL1A in a structurally similar fashion and its promiscuity is due to recognition of backbone atoms and invariant side chains.

  13. These results raise the possibility for involvement of TL1A/DR3/DR3-mediated mechanisms in epithelial-mesenchymal interactions and the development of inflammation-induced intestinal fibrosis in Crohn's disease.

  14. when idiopathic pulmonary fibrosis cells interact with collagen matrix, aberrantly activated Akt increases DcR3 expression via GSK-3beta-NFATc1 and protects IPF cells from the FasL-dependent apoptotic pathway.

  15. Coexpression of TNFRSF6B and PCDHGA3 was observed immunohistochemically in FL18 cells, suggesting potential cooperation in tumor cell maintenance.

  16. Loss of DcR3 impaired the growth and invasive property of HCC cell line of HepG2.

  17. Overexpression of DcR3 was significantly related to the risk of female reproductive cancers (OR=10.69, 95% CI: 6.33-18.05), TNM stage (OR=5.51, 95% CI: 2.83-10.71), differentiation (OR=4.16, 95% CI: 2.28-7.60), lymph node metastasis (OR=5.89, 95% CI: 3.16-10.9), age (OR=0.85, 95% CI: 0.51-1.44), and overall survival time (OR=1.84, 95% CI: 0.58-5.83).

  18. The serum level of DcR3 may be a useful marker for disease activity in ANCA-associated renal vasculitis.

  19. The sDcR3 levels in patients with HIV-1 subtype B were significantly higher than those in patients infected with subtype CRF01_AE. HIV-1 subtype B and slow disease progression were associated with higher levels of sDcR3.

  20. DcR3 inhibits influenza a virus-induced JNK and ERK activation in human macrophages

TNFRSF6B Antigen-Profil

Beschreibung des Gens

This gene belongs to the tumor necrosis factor receptor superfamily. The encoded protein is postulated to play a regulatory role in suppressing FasL- and LIGHT-mediated cell death. It acts as a decoy receptor that competes with death receptors for ligand binding. Over-expression of this gene has been noted in gastrointestinal tract tumors. Read-through transcription into this gene from the neighboring upstream gene, which encodes regulator of telomere elongation helicase 1 (RTEL1), generates a non-coding transcript.

Genbezeichner und Symbole assoziert mit TNFRSF6B

  • TNF receptor superfamily member 6b (TNFRSF6B) Antikörper
  • tumor necrosis factor receptor superfamily, member 11b (tnfrsf11b) Antikörper
  • regulator of telomere elongation helicase 1 (RTEL1) Antikörper
  • TNF receptor superfamily member 6b (tnfrsf6b) Antikörper
  • TNF receptor superfamily member 6b L homeolog (tnfrsf6b.L) Antikörper
  • dcr3 Antikörper
  • DJ583P15.1.1 Antikörper
  • m68 Antikörper
  • M68E Antikörper
  • tr6 Antikörper

Bezeichner auf Proteinebene für TNFRSF6B

decoy receptor 3 , decoy receptor for Fas ligand , tumor necrosis factor receptor superfamily member 6B , tumor necrosis factor receptor superfamily, member 6b , tumor necrosis factor receptor superfamily, member 6b, decoy

GENE ID SPEZIES
8771 Homo sapiens
407674 Danio rerio
789154 Bos taurus
100024799 Monodelphis domestica
100145799 Xenopus (Silurana) tropicalis
100158264 Xenopus laevis
100221010 Taeniopygia guttata
Ausgewählte Anbieter für TNFRSF6B (TNFRSF6B) ELISA Kits
Haben Sie etwas anderes gesucht?